Alto Neuroscience, Inc. Common Stock (ANRO)
Cost of Revenue
$184.00K
TTM · Period ending: · USD
ANRO Cost of Revenue
Latest reported$184.00Kperiod ending
Latest reported$184.00Kperiod ending
ANRO TTM Cost of Revenue ($283.00K → $184.00K)
TTM cost of revenue
High-resolution chart · PNG
ANRO cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 184,000 | |
| 284,000 | |
| 100,000 | |
| 270,000 | |
| 270,000 | |
| 170,000 | |
| 267,000 | |
| 189,000 | |
| 189,000 | |
| 289,000 | |
| 278,000 | |
| 283,000 |